Simplify Propel Opportunities ETF Vs. Crinetics Pharmaceuticals, Inc. Industry Stock Comparison

Buy

70

SURI
Simplify Propel Opportunities ETF

Last Price:

$17.20

Seasonality Move:

10.04%

Sell

34

CRNX
Crinetics Pharmaceuticals, Inc.

Last Price:

$53.22

Seasonality Move:

-13.28%

Buy

70

Simplify Propel Opportunities ETF (SURI) is a Buy

Is Simplify Propel Opportunities ETF a Buy, Sell or Hold?

The current Simplify Propel Opportunities ETF [SURI] share price is $17.16. The Score for SURI is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
SURI is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

Sell

34

Crinetics Pharmaceuticals, Inc. (CRNX) is a Sell

Is Crinetics Pharmaceuticals, Inc. a Buy, Sell or Hold?

The current Crinetics Pharmaceuticals, Inc. [CRNX] share price is $53.24. The Score for CRNX is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
CRNX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

SURI Stock Price Chart

What is Simplify Propel Opportunities ETF's stock price today?

The Simplify Propel Opportunities ETF share price today is $17.16

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SURI is experiencing selling pressure, which indicates risk of future bearish movement.

CRNX Stock Price Chart

What is Crinetics Pharmaceuticals, Inc.'s stock price today?

The Crinetics Pharmaceuticals, Inc. share price today is $53.24

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRNX is experiencing slight selling pressure.

SURI Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.06	Sell
Relative Strength Index (14 RSI):	53.92	Buy
Chaikin Money Flow:	-4335	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(16.68 - 17.66)	Sell
Bollinger Bands (100):	(15.79 - 17.29)	Buy

CRNX Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	1.28	Buy
Relative Strength Index (14 RSI):	65.68	Buy
Chaikin Money Flow:	-209678	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(46.25 - 50.15)	Buy
Bollinger Bands (100):	(35.32 - 47.44)	Buy

SURI Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	16.82	Buy
20-day SMA:	17.02	Buy
50-day SMA:	16.96	Buy
200-day SMA:	15.75	Buy
8-day EMA:	16.92	Buy
20-day EMA:	16.97	Buy
50-day EMA:	16.91	Buy
200-day EMA:	16.72	Buy

CRNX Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	48.77	Buy
20-day SMA:	48.57	Buy
50-day SMA:	45.67	Buy
200-day SMA:	36.1	Buy
8-day EMA:	49.69	Buy
20-day EMA:	48.35	Buy
50-day EMA:	45.87	Buy
200-day EMA:	40.28	Buy

Simplify Propel Opportunities ETF Earnings Growth & SURI Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Crinetics Pharmaceuticals, Inc. Earnings Growth & CRNX Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.23 per share, and an increase next year of $1.51 per share.

Simplify Propel Opportunities ETF Technical Analysis

	Dec 24	Dec 26	Dec 29	Dec 30	Dec 31	Jan 2	Jan 5	Jan 6	Jan 7	Jan 8
	Dec						Jan
	24	26	29	30	31	02	05	06	07	08
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Crinetics Pharmaceuticals, Inc. Technical Analysis

	Dec 23	Dec 24	Dec 26	Dec 29	Dec 30	Dec 31	Jan 5	Jan 6	Jan 7	Jan 8
	Dec							Jan
	23	24	26	29	30	31	05	06	07	08
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):